A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
for Asthma
28 locations incl. Mobile
Sponsor: AstraZeneca
Sex: All·Age: 6 - 18
Code: NCT05692180·Phase 3·Recruiting